Goldman Sachs downgraded Solazyme (NASDAQ: SZYM) from Buy to Neutral with a price target of $13.50. Analyst Brian Lee ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE